Genentech Inc. (DNA)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Genentech Inc. (DNA)
264 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on DNA
- SA Editor Miriam Metzinger(48)
- Centient Biotech Investor(32)
- Mike Huckman(22)
- SA Editor Eli Hoffmann(17)
- SA Editors(16)
Most popular authors
(tracked in watchlists)
- Philip Davis(740)
- Bespoke Investment Group(679)
- Trader Mark(631)
- Bill Cara(482)
- SA Editor Eli Hoffmann(413)
Most commented on authors
- SA Editor Eli Hoffmann(97)
- SA Editor Joan Wickham(44)
- Bill Cara(35)
- SA Editor Miriam Metzinger(34)
- Ohad Hammer(33)
- Selecting 2009 Merger Arbitrages Carefully
- 9 Possible Pharma Deals for 2009
- 2008 Stock Market: 51 Rays of Light
- Genentech's Trastuzumab-Dm1 Shows Great Promise in Treating Breast Cancer
- Reviewing Fortune Magazine's 10 Best Stocks for 2008
- Is There a Legitimate Case for the Healthcare Providers ETF?
- Hedge Fund Tracking: Barry Rosenstein's Jana Partners, Q3 2008
- Five Things Worth Remembering About Healthcare in 2009
- Hedge Fund Tracking: Eton Park Capital (Eric Mindich), Q3 2008
- Immunogen and Exelixis Defy the Recession
- Friday Options Update: DNA, C, UNH, RIMM, WB
- Thursday Options Update: PCLN, DFS, DNA, HBC, CAT & CX
- Genentech and Generex: New HER2/neu Research
- Hedge Fund Tracking: Bruce Kovner's Caxton Associates, Q3 2008
- Merck BioVentures Enters the Generic Biotech Game
- Three Potential Biotech Takeover Targets
- Roche Stalling for Time and Money in Genentech Deal
- More Focused Defensive Index
- Hedge Fund Tracking: Paulson & Co. (John Paulson), Q3 2008
- Nine Pharma Predictions for 2009
- Roche Says It'll Still Buy Genentech, Investors Think Otherwise
- AstraZeneca Trials Provide Zest and Zeal for OSI Pharmaceuticals
- What Are Some of the Best Hedge Fund Managers Doing?
- 5 Health Care Stocks for Value Investors
- Biotech ETFs a Rare Safe Haven
- Updated FDA Decision Date Calendar
- General Electric Moves On Down the Largest Company List
- Market Update: Roche/Genentech Deal, AstraZeneca's New Statin, Yahoo, Microsoft Deal?
- ETFI Global Healthcare Sector PerfomIdex
- Weekly Street Sentiment: Sell-Side Says Get Out, Get Short, Get Safe
- Market Trims Hedges - Fast Money Recap (10/23/08)
- Roche: Why No News About Genentech from Earnings Call?
- Credit Market Trend - Fast Money Recap (10/21/08)
- A Defensive Growth Stock Index
- Stocks Struggle Around the World
- Even Fatter Yields for Pfizer; M&A Targets in the Sector
- Why It's Time to Buy More Immunogen
- Genentech on Roche's Plans: Our Lips Are Sealed
- Genentech's Decision Should Boost Immunogen Stock
- Wall Street Breakfast: Must-Know News
- Market Behaves Sanely - Fast Money Recap (10/14/08)
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
4 new today)